A Clinical Trial of TQC3721 Suspension for Inhalation

Clinical trial NCT05051930 · UNKNOWN

Trial details

NCT number: NCT05051930
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2021-10-18
Primary completion: 2022-10-31
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.